Advertisement
  • Reuters

    Pfizer reports patient death in Duchenne gene therapy study

    "A fatal serious adverse event was reported as cardiac arrest for a participant in the Phase 2 DAYLIGHT study," a company spokesperson told Reuters in an emailed response. The trial tested boys 2 years to less than 4 years of age with DMD, a genetic muscle wasting disorder in which most patients lack the protein dystrophin which keeps muscles intact.

  • SNY

    Mets at Cardinals: How to watch on SNY on May 7, 2024

    Here's how to watch the Mets game on SNY online or via the SNY app.

  • Reuters

    UPDATE 1-AstraZeneca to withdraw COVID-19 vaccine globally, Telegraph reports

    Anglo-Swedish drugmaker AstraZeneca is withdrawing its COVID-19 vaccine worldwide, the Telegraph reported on Tuesday. The vaccine can no longer be used in the European Union after the company voluntarily withdrew its "marketing authorisation", the report stated. The application to withdraw the vaccine was made on March 5 and came into effect on May 7, according to the report, which added that similar applications would be made in the UK and other countries that had approved the vaccine, known as Vaxzevria, in the coming months.